Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction -- Data Supplement - Supporting Figures -- Proceedings of the National Academy of Sciences

Supporting information for Schmollinger et al. (2003) Proc. Natl. Acad. Sci. USA, 10.1073/pnas.053031100

JPEG Image

Fig. 6.
ML-IAP-expressing autologous melanoma cells. Lysates prepared from WT M34 cells and M34 cells transduced with pMFG-ML-IAP retroviral supernatants were subjected to Western analysis by using K030 sera. The predicted size of ML-IAP is 30.8 kDa.